Association of disease duration and PASI response rates at week 12 in patients with moderate-to-severe plaque psoriasis receiving biologics in the real-world psoriasis study of health outcomes (PSoHO)

• Hoofdauteurs: Andreas Pinter (Auteur), Kilian Eyerich (Auteur), Antonio Costanzo (Auteur), Alyssa Garrelts (Auteur), Christopher Schuster (Auteur), Can Mert (Auteur), Anastasia Lampropoulou (Auteur), Konstantinos Fotiou (Auteur), Julia-Tatjana Maul (Auteur), Kim A. Papp (Auteur)
• Formaat: Boek
• Gepubliceerd in: Taylor & Francis Group, 2024-12-01T00:00:00Z.
• Onderwerpen: article
• Online toegang: Connect to this object online.

AbstractPurpose Currently, in the treatment of moderate-to-severe psoriasis (PsO) there is a lack of evidence demonstrating optimal biologic treatment response with respect to disease duration. The aim of this post-hoc analysis, using real world data from the Psoriasis Study of Health Outcomes (PSoH...